- Home
- MQ vs IRON Comparison
MQ vs IRON Comparison
Compare MQ & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MQ
- IRON
- Stock Information
- Founded
- MQ 2010
- IRON 2017
- Country
- MQ United States
- IRON United States
- Employees
- MQ N/A
- IRON N/A
- Industry
- MQ Computer Software: Prepackaged Software
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- MQ Technology
- IRON Health Care
- Exchange
- MQ Nasdaq
- IRON Nasdaq
- Market Cap
- MQ 1.9B
- IRON 1.9B
- IPO Year
- MQ 2021
- IRON N/A
- Fundamental
- Price
- MQ $3.73
- IRON $41.25
- Analyst Decision
- MQ Hold
- IRON Strong Buy
- Analyst Count
- MQ 14
- IRON 10
- Target Price
- MQ $5.09
- IRON $83.80
- AVG Volume (30 Days)
- MQ 8.1M
- IRON 427.6K
- Earning Date
- MQ 05-07-2025
- IRON 05-08-2025
- Dividend Yield
- MQ N/A
- IRON N/A
- EPS Growth
- MQ N/A
- IRON N/A
- EPS
- MQ 0.05
- IRON N/A
- Revenue
- MQ $506,995,000.00
- IRON N/A
- Revenue This Year
- MQ $20.99
- IRON N/A
- Revenue Next Year
- MQ $20.55
- IRON N/A
- P/E Ratio
- MQ $75.11
- IRON N/A
- Revenue Growth
- MQ N/A
- IRON N/A
- 52 Week Low
- MQ $3.37
- IRON $25.64
- 52 Week High
- MQ $6.25
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- MQ 38.59
- IRON 29.34
- Support Level
- MQ $4.08
- IRON $51.57
- Resistance Level
- MQ $4.38
- IRON $50.14
- Average True Range (ATR)
- MQ 0.18
- IRON 2.22
- MACD
- MQ -0.07
- IRON -0.59
- Stochastic Oscillator
- MQ 5.73
- IRON 7.98
About MQ Marqeta Inc.
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.